← Back to Search

Antiviral

AT-752 for Dengue Fever

Phase 1
Waitlist Available
Research Sponsored by Atea Pharmaceuticals, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2 until 28 days post virus inoculation
Awards & highlights

Study Summary

This trial will study whether AT-752 is safe and effective in healthy people who are infected with dengue virus.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 until 28 days post virus inoculation
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2 until 28 days post virus inoculation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean quantitative RNAemia (peak and duration and area under the plasma concentration versus time curve [AUC])

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: AT-752Experimental Treatment1 Intervention
AT-752 administered orally for 14 days
Group II: PlaceboPlacebo Group1 Intervention
Matching placebo administered orally for 14 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AT-752
2021
Completed Phase 1
~70

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Atea Pharmaceuticals, Inc.Lead Sponsor
27 Previous Clinical Trials
3,812 Total Patients Enrolled
1 Trials studying Dengue Fever
21 Patients Enrolled for Dengue Fever

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
North Carolina
Virginia
Other
What site did they apply to?
Atea Study Site
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model
2022. "Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05366439.
~2 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top